Mendel and More

Photo: Courtesy of M. Matsuoka, Reprinted with permission from Nature ©2001 A COMPARISON: The effect of a mutant gibberellin-biosynthesis gene is shown in rice plants; on the left, wild type; on the right, IR8 (sd1). During the summer of 1997, two research groups succeeded in bringing closure to a classic tale in genetics. After 131 years, they identified one of Mendel's pea genes at the molecular level. The gene, called Le, controls stem length--plants with defective copies are sho

Written byBarry Palevitz
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

During the summer of 1997, two research groups succeeded in bringing closure to a classic tale in genetics. After 131 years, they identified one of Mendel's pea genes at the molecular level. The gene, called Le, controls stem length--plants with defective copies are shorter than normal. Characterized in both pea and Arabidopsis, the gene encodes an enzyme called gibberellin 3b-hydroxylase, which converts two precursors of the growth regulator gibberellin into active forms, including gibberellin 1.1,2 Le was the second of Mendel's genes to be identified. Re-searchers pulled out the first--for a starch-branching enzyme that in defective form causes the wrinkled seed trait--12 years ago.3

Now a gene called GA20ox-2 encoding another enzyme in the gibberellin biosynthetic pathway has been conquered, this time in rice.4 The enzyme is GA20 oxidase, which catalyzes three steps in the pathway leading to production of gibberellin 20, a substrate for the b- hydroxylase. Four alleles ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies